MedDataX Logo

The Effect Of Antenatal Corticosteroids On Early And Late Perinatal Outcomes

NCT ID: NCT06164080

Last Updated: 2023-12-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

459 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-06-01

Study Completion Date

2022-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, the investigators aims to evaluate whether antenatal corticosteroid administration to women likely to give birth in the late preterm period will reduce early and late neonatal complications and contribute to the literature in this sense.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a single-center prospective case-control study investigating the effect of antenatal corticosteroids administered in the late preterm period on early and late perinatal outcomes. 459 patients who gave birth between 34-37 weeks between June 1,2021 to October 1,2022 in the Obstetrics and Gynecology Clinic of the University of Health Sciences were included. Patient were divided into two groups antenatal corticosteroid administration (n:231) and non-administration (n:228). Postpartum early and late perinatal outcomes were compared between these two groups.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Preterm Pregnancy Antenatal Corticosteroid Perinatal Problems

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Antenatal corticosteroids Late preterm pregnancy Late perinatal outcomes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Antenatal corticosteroid non-administration

Pregnant women who did not use antenatal corticosteroid before 34 weeks

Group Type NO_INTERVENTION

No interventions assigned to this group

Antenatal corticosteroid administration

Pregnant women using antenatal corticosteroids for any reason before 34 weeks

Group Type ACTIVE_COMPARATOR

participants receiving Corticosteroid

Intervention Type OTHER

Pregnant women using antenatal corticosteroids for any reason before 34 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

participants receiving Corticosteroid

Pregnant women using antenatal corticosteroids for any reason before 34 weeks

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

betamethasone dekort

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All pregnant women who had normal vaginal delivery, cesarean section or operative delivery between 34-37 weeks
* Singleton pregnancies resulting in a live birth

Exclusion Criteria

* Twin pregnancies
* All births before 34 weeks or after 37 weeks
* Pregnant women with intrauterine ex fetus
* Fetuses with major congenital and chromosomal abnormalities
* Pregnant women who administrated antenatal corticosteroids for any reason before 34 weeks
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sanliurfa Mehmet Akif Inan Education and Research Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nefise Nazlı YENIGUL

Ph.D. Assistant Professor Department of Obstetrics and Gynecology

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nefise Nazlı YENIGUL

Bursa, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2011-KAEK-25 2021/05-10

Identifier Type: -

Identifier Source: org_study_id